Literature DB >> 19963232

Pathology in dogs with experimental canine H3N2 influenza virus infection.

K Jung1, C S Lee, B K Kang, B K Park, J S Oh, D S Song.   

Abstract

Avian-lineage H3N2 canine influenza virus (CIV)-associated respiratory disease, which can be fatal, emerged in South Korean dogs in 2007. We show here that dogs experimentally infected with CIV only developed respiratory tract diseases, as no extrapulmonary lesions and virus antigens were detected. This differs from the multiorgan diseases that avian influenza H5N1 induces in small experimental animals. However, the CIV-infected dogs developed a distinctively severe, long-persistent bronchointerstitial pneumonia, which differs from the acute but short-term bronchopneumonia that human (H1N1 and H3N2) influenza cause in rodents and ferrets. Histopathology and in situ TUNEL assays revealed that the neutrophils infiltrating the lesions were undergoing apoptosis, which probably reflects the attempts by the body to maintain appropriate numbers of neutrophils for defense against secondary bacterial infections. Our observations suggest that neutrophils along with the related chemoattractant cytokines (TNF-alpha, IL-1 and IL-8, etc.) may play a key role in the pathogenesis of H3N2 CIV in dogs. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19963232     DOI: 10.1016/j.rvsc.2009.11.007

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  9 in total

1.  Differential pathological and immune responses in newly weaned ferrets are associated with a mild clinical outcome of pandemic 2009 H1N1 infection.

Authors:  Stephen S H Huang; David Banner; Norbert Degousee; Alberto J Leon; Louling Xu; Stephane G Paquette; Thirumagal Kanagasabai; Yuan Fang; Salvatore Rubino; Barry Rubin; David J Kelvin; Alyson A Kelvin
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

Review 2.  A review of the pathology and treatment of canine respiratory infections.

Authors:  Miranda D Vieson; Pablo Piñeyro; Tanya LeRoith
Journal:  Vet Med (Auckl)       Date:  2012-06-26

3.  Genetic characterization of avian-origin H3N2 canine influenza viruses isolated from Guangdong during 2006-2012.

Authors:  Heng Wang; Kun Jia; Wenbao Qi; Minze Zhang; Long Sun; Huanbin Liang; Guohao Du; Likai Tan; Zhenwen Shao; Jiahui Ye; Lingshuang Sun; Zhenpeng Cao; Ye Chen; Pei Zhou; Shuo Su; Shoujun Li
Journal:  Virus Genes       Date:  2013-03-06       Impact factor: 2.332

4.  Monoclonal antibody specific to HA2 glycopeptide protects mice from H3N2 influenza virus infection.

Authors:  Xing Xie; Yan Lin; Maoda Pang; Yanbing Zhao; Dildar Hussain Kalhoro; Chengping Lu; Yongjie Liu
Journal:  Vet Res       Date:  2015-03-19       Impact factor: 3.683

5.  Inter- and intraspecies transmission of canine influenza virus (H3N2) in dogs, cats, and ferrets.

Authors:  Hyekwon Kim; Daesub Song; Hyoungjoon Moon; Minjoo Yeom; Seongjun Park; Minki Hong; Woonseong Na; Richard J Webby; Robert G Webster; Bongkyun Park; Jeong-Ki Kim; Bokyu Kang
Journal:  Influenza Other Respir Viruses       Date:  2012-05-23       Impact factor: 4.380

Review 6.  Canine influenza.

Authors:  Edward J Dubovi
Journal:  Vet Clin North Am Small Anim Pract       Date:  2010-09-01       Impact factor: 2.093

7.  Experimental infection of dogs with H3N2 canine influenza virus from China.

Authors:  X J Zeng; Y Lin; Y B Zhao; C P Lu; Y J Liu
Journal:  Epidemiol Infect       Date:  2013-03-19       Impact factor: 4.434

8.  Seroprevalence of three influenza A viruses (H1N1, H3N2, and H3N8) in pet dogs presented to a veterinary hospital in Ohio.

Authors:  Hyesun Jang; Yasmine K Jackson; Joshua B Daniels; Ahmed Ali; Kyung-Il Kang; Mohamed Elaish; Chang-Won Lee
Journal:  J Vet Sci       Date:  2017-08-31       Impact factor: 1.672

Review 9.  The induction and consequences of Influenza A virus-induced cell death.

Authors:  Georgia K Atkin-Smith; Mubing Duan; Weisan Chen; Ivan K H Poon
Journal:  Cell Death Dis       Date:  2018-09-25       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.